1) Kannel W. B., Castelli W. P., Gordon T., McNamara P. M., Ann. Intern. Med., 74, 1-12 (1971).
2) Stamler J., Wentworth D., Neaton J. D., JAMA, 256, 2823-2828 (1986).
3) Pharma Marketing Survey Res. Lab., “The Estimated Market of the Ethics Drugs for Cardiovascular Disease in 1997, Yakuji Handbook,” Jiho Ltd., Tokyo, 1998, p. 279.
4) Sueta C. A., Chowdhury M., Boccuzzi S. J., Smith S. C., Alexander C. M., Londhe A., Lulla A., Simpson R. J., Am. J. Cardiol., 83, 1303-1307 (1999).